Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial.
Campbell MT, Balderrama-Brondani V, Jimenez C, Tamsen G, Marcal LP, Varghese J, Shah AY, Long JP, Zhang M, Ochieng J, Haymaker C, Habra MA.
Campbell MT, et al. Among authors: varghese j.
Lancet Oncol. 2024 Apr 9:S1470-2045(24)00095-0. doi: 10.1016/S1470-2045(24)00095-0. Online ahead of print.
Lancet Oncol. 2024.
PMID: 38608694